-
Short- and Longer-Term Healthcare Resource Utilization and Related Costs of Stroke in the Brazilian Private Market from 2019 to 2023
Mar 10, 2025, 14:00 PM -
Data Extraction in Literature Reviews Using an Artificial Intelligence Model: Prompt Development and Testing
Mar 10, 2025, 14:00 PM -
Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study
Mar 10, 2025, 14:00 PM -
Costs of Care for Patients With Triple Negative Metastatic Breast Cancer: A Retrospective US Claims Data Study
Mar 10, 2025, 14:00 PM -
The Cost-effectiveness Analysis of Gene Therapy for Severe Hemophilia B Patients in China: A Microsimulation Experiment Study
Mar 10, 2025, 14:00 PM -
Using Regression Discontinuity in Time Design for Real-World Comparative Effectiveness: A Case Study for the Second-Line Use of Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Cost and Prevalence of Pre-Analytical Errors: A Narrative Review
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Intravenous Ferric Carboxy Maltose Versus Iron Sucrose to Treat Anemia in Pregnancy in Indian Context
Mar 10, 2025, 14:00 PM -
Estimating the Burden of Illness and Healthcare Costs Among Incident Intermittent Catheter Users: A Comparison of Neurogenic and Non-Neurogenic Bladder Cohorts in the US
Mar 10, 2025, 14:00 PM -
Impact of Newborn Screening for Duchenne Muscular Dystrophy: A Model-Based Analysis
Mar 10, 2025, 14:00 PM -
Are Patients With Major Depressive Disorder (MDD) Getting Access to Innovation in HTA Markets? Review of Reimbursement Decisions of Pharmacotherapies for MDD in Europe, Australia, and Canada From 2001 to 2021
Mar 10, 2025, 14:00 PM -
Health Utility Values of Canadian Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and the Economic Burden of Neovascular Age-Related Macular Degeneration (nAMD): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
How HTA Should Consider the Global Value of Health Products to Support Public Decision?
Mar 10, 2025, 14:00 PM -
A Contemporary Analysis of Utilization, Clinical Outcomes and Costs of Robotic-Assisted, Laparoscopic, and Open Partial Nephrectomy Using the National Inpatient Sample
Mar 10, 2025, 14:00 PM -
Costs of Type 2 Diabetes Mellitus and Obesity in Colombian Caribbean Poor Population: A Top-Down Approach from a Cardiovascular Risk Cohort, 2020-2022
Mar 10, 2025, 14:00 PM -
The Unseen Progress: How PROs May Overlook the Value of Slowing Degenerative Decline
Mar 10, 2025, 14:00 PM -
Utilization and Impact of GLP-1s: Patient-Reported Healthcare Resource Utilization and Costs in Patients With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Adverse Events Associated With Recently Approved Alzheimer's Drugs: A Real-World Pharmacovigilance Study
Mar 10, 2025, 14:00 PM -
The Costs Associated with Healthcare Resource Use and Work Productivity for Care Partners of Multiple Myeloma Patients in the United States and Europe
Mar 10, 2025, 14:00 PM
